GHK-Cu + BPC-157 + TB-500 (Glow Stack)

What Is the Glow Stack?

The Glow Stack pairs three peptides that each carry a distinct research focus. GHK-Cu is a naturally occurring copper-binding peptide studied for its role in collagen production and skin structure. BPC-157 is a peptide originally identified in the stomach, studied for tissue repair and blood vessel formation. TB-500 is a fragment of Thymosin Beta-4, a protein involved in how cells move and reorganize, studied for its role in cell migration during tissue repair.

The "Glow" nickname reflects the research community's interest in combining a structural, skin-focused peptide with two peptides more commonly studied for general tissue repair. Worth noting: most of the published research studies each peptide individually rather than as a three-part combination.

What This Stack Is Being Researched For

• Skin Structure and Collagen

  GHK-Cu's research base centers on collagen production and the enzymes involved in maintaining connective tissue structure.^[1]

• Tissue and Blood Vessel Support

  BPC-157's research base centers on blood vessel formation and gut-related signaling, both of which relate to how tissue receives blood flow and support.^[3][4]

• Cell Migration

  TB-500's research base centers on actin, the protein that lets cells move and change shape, which has made it a subject of study in wound closure and directed cell movement.^[2]

How the Stack Works

• GHK-Cu and Collagen Support

  Research points to GHK-Cu delivering copper to enzymes involved in cross-linking collagen fibers, while signaling skin cells to increase production of structural proteins that support skin's underlying framework.^[1]

• BPC-157 and Blood Flow

  Research points to BPC-157 affecting new blood vessel formation and nitric oxide signaling, both of which relate to how well blood reaches an area of tissue.^[3][4]

• TB-500 and Cell Movement

  Research points to TB-500 interacting with actin to help direct the movement of cells like fibroblasts toward an area, a process relevant to how tissue closes and rebuilds after injury.^[2]

• Why the Three Are Paired

  Since each peptide's research base sits at a different stage of tissue repair, structural building, blood flow, and cell movement, researchers combining them are generally interested in whether addressing all three angles together supports a more complete picture than any one peptide alone.

Reconstitution and Handling

All three peptides are typically supplied as a lyophilized powder in a sealed vial and reconstituted with bacteriostatic water before use in a research setting. Water should be added slowly rather than injected directly into the powder, and the vial should be swirled, not shaken.

Since the amount of water used affects the concentration of the final solution, researchers often use a dosage calculator to work this out for each peptide separately before mixing. Once reconstituted, all three solutions are kept refrigerated to help preserve stability.

Key Takeaways

The Glow Stack brings together three peptides with genuinely different research focuses rather than three versions of the same mechanism: GHK-Cu for structural skin support, BPC-157 for blood vessel formation, and TB-500 for cell movement. Most of what's published studies each one separately, with GHK-Cu carrying the most human-relevant research history of the three. Treat the combination as a research-community practice built on complementary mechanisms rather than an established body of combined-use evidence.

Frequently Asked Questions

Sources and Research

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
2. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368.
3. Vuksic T, Zoricic I, Brcic L, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease heals ileoileal anastomosis in the rat. Surg Today. 2007;37(9):768-777.
4. Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333.